C110H148N20O14S4 — CID 161135008
(2S)-N-(2-acetamido-4-phenyl-1,3-thiazol-5-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-N-(2-acetamido-5-phenyl-1,3-thiazol-4-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(4-phenyl-1,2,5-thiadiazol-3-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(5-phenylthiadiazol-4-yl)pyrrolidine-2-carboxamide (PubChem CID 161135008) has the molecular formula C110H148N20O14S4 and a molecular weight of 2102.79 g/mol. Its IUPAC name is (2S)-N-(2-acetamido-4-phenyl-1,3-thiazol-5-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-N-(2-acetamido-5-phenyl-1,3-thiazol-4-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(4-phenyl-1,2,5-thiadiazol-3-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(5-phenylthiadiazol-4-yl)pyrrolidine-2-carboxamide.
| Compound Name | (2S)-N-(2-acetamido-4-phenyl-1,3-thiazol-5-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-N-(2-acetamido-5-phenyl-1,3-thiazol-4-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(4-phenyl-1,2,5-thiadiazol-3-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(5-phenylthiadiazol-4-yl)pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 161135008 |
| Molecular Formula | C110H148N20O14S4 |
| Molecular Weight | 2102.79 g/mol |
| Exact Mass | 2101.04 |
| IUPAC Name | (2S)-N-(2-acetamido-4-phenyl-1,3-thiazol-5-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-N-(2-acetamido-5-phenyl-1,3-thiazol-4-yl)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(4-phenyl-1,2,5-thiadiazol-3-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S)-2-cyclohexyl-2-[[(2R)-2-methylbutanoyl]amino]acetyl]-N-(5-phenylthiadiazol-4-yl)pyrrolidine-2-carboxamide |
| SMILES | CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1nc(NC(C)=O)sc1-c1ccccc1)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1nnsc1-c1ccccc1)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1nsnc1-c1ccccc1)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1sc(NC(C)=O)nc1-c1ccccc1)C1CCCCC1 |
| InChI | InChI=1S/2C29H39N5O4S.2C26H35N5O3S/c1-4-18(2)26(36)31-23(20-12-7-5-8-13-20)28(38)34-17-11-16-22(34)27(37)32-25-24(21-14-9-6-10-15-21)39-29(33-25)30-19(3)35;1-4-18(2)25(36)31-24(21-14-9-6-10-15-21)28(38)34-17-11-16-22(34)26(37)33-27-23(20-12-7-5-8-13-20)32-29(39-27)30-19(3)35;1-3-17(2)24(32)27-21(18-11-6-4-7-12-18)26(34)31-16-10-15-20(31)25(33)28-23-22(35-30-29-23)19-13-8-5-9-14-19;1-3-17(2)24(32)27-22(19-13-8-5-9-14-19)26(34)31-16-10-15-20(31)25(33)28-23-21(29-35-30-23)18-11-6-4-7-12-18/h6,9-10,14-15,18,20,22-23H,4-5,7-8,11-13,16-17H2,1-3H3,(H,31,36)(H,32,37)(H,30,33,35);5,7-8,12-13,18,21-22,24H,4,6,9-11,14-17H2,1-3H3,(H,31,36)(H,33,37)(H,30,32,35);5,8-9,13-14,17-18,20-21H,3-4,6-7,10-12,15-16H2,1-2H3,(H,27,32)(H,28,33);4,6-7,11-12,17,19-20,22H,3,5,8-10,13-16H2,1-2H3,(H,27,32)(H,28,30,33)/t18-,22+,23+;18-,22+,24+;17-,20+,21+;17-,20+,22+/m1111/s1 |
| InChIKey | UMRHWOOBWCUBHG-ZSPSMDTISA-N |
| XLogP | 18.11 |
| TPSA | 449.58 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 148 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2102.79 |
| LogP ≤ 5 | 18.11 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 24 |